Lyophilized Live Attenuated HAV Vaccine (Changchun Changsheng Life Sciences)

甲型肝炎减毒活疫苗（长春长生生物）

Report date: 2025/08/01 16:02:59

Base Information

Drug NameLyophilized Live Attenuated HAV Vaccine (Changchun Changsheng Life Sciences)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccineVaccines > National Immunization Program > Immunization program vaccine(Class I)

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHepatitis A

Global Approved IndicationsHepatitis A

Approved Indications in ChinaHepatitis A

Original Approved Country/TerritoryMainland China

Original Approved Date2001/01/01

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusWithdrawn

Highest Status in ChinaWithdrawn

Originator CompaniesChangchun Longevity Biological Technology Limited Liability Company

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesChangchun Longevity Biological Technology Limited Liability Company

Active IndicationsN/A

Inactive IndicationsHepatitis A

Other Information

ATC CodeJ07BC